Korro Bio, Inc.

KRRO

US5009461089

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-12 pm EDT			5-day change	1st Jan Change
49.15 ^USD	+7.20%		+34.55%	+2.55%

Jul. 01	Korro Bio Joins Russell 2000, 3000, Microcap Indexes	MT
Jul. 01	Korro Bio, Inc.(NasdaqCM:KRRO) added to Russell Small Cap Comp Value Index	CI

Korro Bio, Inc. Announces Resignation of Steve Colletti as Chief Scientific Officer, Effective August 2, 2024

June 21, 2024 at 04:16 pm EDT

On June 17, 2024, Korro Bio, Inc. announced Steve Colletti, Ph.D., notified the company of his intent to resign as its Chief Scientific Officer effective August 2, 2024.

Latest news about Korro Bio, Inc.

Korro Bio Joins Russell 2000, 3000, Microcap Indexes	Jul. 01	MT
Korro Bio, Inc.(NasdaqCM:KRRO) added to Russell Small Cap Comp Value Index	Jun. 30	CI
Korro Bio, Inc.(NasdaqCM:KRRO) added to Russell Small Cap Completeness Index	Jun. 30	CI
Korro Bio, Inc.(NasdaqCM:KRRO) added to Russell Microcap Growth Index	Jun. 30	CI
Korro Bio, Inc.(NasdaqCM:KRRO) added to Russell 3000 Value Index	Jun. 30	CI
Korro Bio, Inc.(NasdaqCM:KRRO) added to Russell 2000 Index	Jun. 30	CI
Korro Bio, Inc.(NasdaqCM:KRRO) added to Russell 3000E Index	Jun. 30	CI
Korro Bio, Inc.(NasdaqCM:KRRO) added to Russell 2500 Value Index	Jun. 30	CI
Korro Bio, Inc.(NasdaqCM:KRRO) added to Russell Microcap Index	Jun. 30	CI
Korro Bio, Inc.(NasdaqCM:KRRO) added to Russell 2500 Growth Index	Jun. 30	CI
Korro Bio, Inc.(NasdaqCM:KRRO) added to Russell Small Cap Comp Growth Index	Jun. 30	CI
Korro Bio, Inc.(NasdaqCM:KRRO) added to Russell 3000E Growth Index	Jun. 30	CI
Korro Bio, Inc.(NasdaqCM:KRRO) added to Russell 3000 Growth Index	Jun. 30	CI
Korro Bio, Inc.(NasdaqCM:KRRO) added to Russell 2000 Value Index	Jun. 30	CI
Korro Bio, Inc.(NasdaqCM:KRRO) added to Russell 2000 Growth Index	Jun. 30	CI
Korro Bio, Inc.(NasdaqCM:KRRO) added to Russell 2000 Dynamic Index	Jun. 30	CI
Korro Bio, Inc.(NasdaqCM:KRRO) added to Russell Microcap Value Index	Jun. 30	CI
Korro Bio, Inc.(NasdaqCM:KRRO) added to Russell 2500 Index	Jun. 30	CI
Korro Bio, Inc.(NasdaqCM:KRRO) added to Russell 3000 Index	Jun. 30	CI
Korro Bio, Inc.(NasdaqCM:KRRO) added to Russell 3000E Value Index	Jun. 30	CI
Korro Bio, Inc. Announces Resignation of Steve Colletti as Chief Scientific Officer, Effective August 2, 2024	Jun. 21	CI
HC Wainwright Adjusts Korro Bio's Price Target to $100 From $115, Keeps Buy Rating	May. 15	MT
Korro Bio Q1 Net Loss Shrinks; Kemi Olugemo Appointed as Chief Medical Officer	May. 14	MT
Korro Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 14	CI
Korro Bio, Inc. Announces the Appointment of Kemi Olugemo, M.D. as Chief Medical Officer	May. 14	CI

Korro Bio, Inc. is a biopharmaceutical company. The Company discovers, develops, and commercializes genetic medicines based on editing ribonucleic acid (RNA), enabling treatment of both rare and highly prevalent diseases. The Company is generating a portfolio of differentiated programs that are designed to harness the bodyâs natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, it is expanding the reach of genetic medicines. Its Oligonucleotide Promoted Editing of RNA (OPERA) is a foundational platform for RNA editing, which is designed to edit RNA in vivo by delivering an oligonucleotide guide that can target specific RNA sequences. The Companyâs first development candidate, KRRO-110, is in development as a potential treatment for Alpha-1 Antitrypsin Deficiency (AATD), that has the potential to be disease-modifying and provide a differentiated therapeutic option.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

49.15 USD

Average target price

126.2 USD

Spread / Average Target

+156.87%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
KORRO BIO, INC.	+2.55%	456M
MODERNA, INC.	+22.10%	46.55B
LONZA GROUP AG	+46.45%	41.84B
IQVIA HOLDINGS INC.	-3.12%	40.84B
ALNYLAM PHARMACEUTICALS, INC.	+36.10%	32.95B
CELLTRION, INC.	-6.30%	28.27B
ICON PUBLIC LIMITED COMPANY	+18.71%	27.78B
UNITED THERAPEUTICS CORPORATION	+46.15%	14.26B
MEDPACE HOLDINGS, INC.	+44.52%	13.69B
BIO-TECHNE CORPORATION	+0.19%	12.18B

Other Biotechnology & Medical Research

Korro Bio, Inc.

Equities

KRRO

US5009461089

Biotechnology & Medical Research

Korro Bio, Inc. Announces Resignation of Steve Colletti as Chief Scientific Officer, Effective August 2, 2024

Latest news about Korro Bio, Inc.

Chart Korro Bio, Inc.

Company Profile

Income Statement Evolution

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Biotechnology & Medical Research